GENE ONLINE|News &
Opinion
Blog

BioJapan
Sumitomo Pharma’s Comeback Story: Reinventing a Century-Old Giant in a Post-Patent Era
2025-04-22
Japan’s Red Biotechnology and International Business Partnering Take Spotlight on BioJapan 2023
2023-11-03
Bio Japan 2021 Highlights: The Commercialization of iPS Cells and the Key to Improving Clinical Trials
2022-02-14
Spotlight on Bio Japan 2021: How Data Governance Can Prepare Us for The Future in Global Healthcare
2021-12-09
2021 BioJapan Highlights: How Can Metabolomics and Lipidomics Deepen Microbiome Research?
2021-10-14
Weekly in Asia|Oct-1
2019-10-14
BioJapan 2019 Kicks Off with Importances on New Bioeconomy Strategy
2019-10-10
Highlights on BioJapan 2018 – Updates on the Development of Cell Therapy and the Regenerative Medicine Ecosystem in Japan
2018-10-22
Live Report – 2018 BioJapan: Witness Japan’s biotechnology industry development policy and the innovation of pharmaceutical industry
2018-10-11
LATEST
Takeda R&D President Andy Plump and GV Managing Partner Krishna Yeshwant Announce Retirements
2026-09-12
Shine Spect USA Updates Clinical and Safety Guidelines for Xenon Xe-133 Gas
2026-09-11
Amorepacific Updates Hera Black Cushion Ingredient Disclosures for Ten Foundation Shades
2026-09-11
AvKARE Updates Prescribing Information for Etonogestrel and Ethinyl Estradiol Vaginal Ring
2026-09-11
Record Investor Attendance at NLS Days 2026 Drives Nordic Life Science Dealmaking
2026-09-11
Disc Medicine and Silence Therapeutics Develop Polycythemia Vera Treatments to Compete With Takeda and Protagonist
2026-09-11
Leucine Supplementation Linked to Reduced Lymphoid Malignancy Growth and Improved Survival in Study
2026-09-11
Scroll to Top